Chicago, Illinois (PRWEB) August 13, 2015
Analyte Health, a digital health company specializing in telehealth and diagnostic testing, announced today that Richard Foust has joined the company as Chief Commercial Officer, reporting to CEO Dr. Frank Cockerill.
Foust will have oversight of the expansion of Analyte Health into new markets, further extending ways the company activates health consumers to bridge gaps in care. Analyte Health sets the standard for improving access to convenient and affordable care for the detection, treatment and prevention of infectious and chronic disease with personalized, on-demand access to doctors and follow-up services.
Richard Foust has spent more than 17 years focused on the development of innovative healthcare solutions that have transformed the treatment of patients with cardiovascular disease. Prior to joining Analyte Health, Richard held several leadership roles with Abbott and Guidant and brings a depth of strategic and commercial experience across product development, global marketing and sales.
“Richard brings to Analyte Health an ideal blend of healthcare and strategic business experience,” said Frank Cockerill, Chief Executive Officer. “He shares our values and our emphasis on creating a very high quality patient experience. With his background building domestic and international teams, Richard has shown himself to be a forward-thinking leader and has a strong track record.”
“I am excited to be a part of giving consumers access to best-in-class virtual clinic that uses diagnostics as a means of determining medical services, said Richard Foust. “The combination of creative service design innovation, digital technology and committed medical professionals gives Analyte Health a strong basis to make a major impact on the way people take control of their health.”
Read more about Analyte Health here: http://www.analytehealth.com/about-us/
About Analyte Health, Inc.
Analyte Health is a digital healthcare company specializing in diagnostics and care delivery. Its mission is to provide convenient access to education, navigation, diagnostic testing, personalized results and recommendations to consumers through its digital clinics. Analyte Health offers access via the phone and the web to a national team of doctors and partner diagnostic labs. More information about the company is available at http://www.AnalyteHealth.com.
Analyte Health, Inc. is a privately held company. This press release may be deemed to contain forward-looking statements, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected benefits to consumers from using Analyte Health's services. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results due to a variety of risks and uncertainties, including, among other things, the potential impact of regulatory and third party payer developments in the field of telehealth, general business and economic conditions, changes in arrangements with vendors or suppliers, and costs or delays in obtaining or maintaining regulatory approvals and licenses. Any forward-looking statements in this release are based on limited information currently available to Analyte Health, which is subject to change, and Analyte Health will not necessarily update the information.
CONTACT: Michelle Sobel, 708-602-2607, michelle(at)analytehealth(dot)com